Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Head & Neck 1

Conditions

Tongue Neoplasms 1Squamous Cell Carcinoma of Head and Neck 1Prostatic Neoplasms 1Pathologic Complete Response 1Neoplasm Metastasis 1Mouth Neoplasms 1Melanoma 1Lymphoid Interstitial Pneumonia 1Lymphedema 1Head and Neck Neoplasms 1Fibrosis 1Carcinoma, Non-Small-Cell Lung 1

Interventions

Nivolumab 2Gefitinib 2Biopsy 2vandetanib 1linrodostat 1ficlatuzumab 1durvalumab 1X-Rays 1Trioxsalen 1Rhinoplasty 1Restraint, Physical 1Radiotherapy, Intensity-Modulated 1Phototherapy 1Photochemotherapy 1Pemetrexed 1Optical Imaging 1Methods 1Metformin 1Ipilimumab 1Independent Medical Evaluation 1Immunohistochemistry 1Gemcitabine 1Educational Status 1Dihematoporphyrin Ether 1Cetuximab 1Carboplatin 1CTLA-4 Antigen 11-phenyl-3,3-dimethyltriazene 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Lymphoid Interstitial Pneumonia × Independent Medical Evaluation × Clear all
NCT01816841 2020-01-30

Direct Visual Fluorescence in Finding Oral Cancer in High-Risk Patients and Patients Undergoing Routine Dental Care

Ohio State University Comprehensive Cancer Center

Phase NA Completed
68 enrolled
Head & Neck

Lymphoid Interstitial Pneumonia, Squamous Cell Carcinoma of Head and Neck, Mouth Neoplasms, Tongue Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡